The ubiquitin conjugation system plays an important role in immune regulation; however, the ubiquitin-specific proteases (USPs) that carry out deubiquitination of cellular substrates are poorly understood. Here we show that in vivo knockdown of the deubiquitinating enzyme USP9X attenuates T-cell proliferation. In addition, naïve CD4 + T cells from USP9X knockdown chimeric mice display decreased cytokine production and T helper cell differentiation in vitro, which we confirmed in vivo by performing adoptive transfer of transgenic T cells and subsequent immunization. USP9X silencing in both a human T-cell line and mouse primary T cells reduced T-cell receptor (TCR) signaling-induced NF-κB activation. Mechanistically, USP9X interacts with Bcl10 of the Carma1-Bcl10-Malt1 (CBM) complex and removes the TCR-induced ubiquitin chain from Bcl10, which facilitates the association of Carma1 with Bcl0-Malt1. These results demonstrate that USP9X is a crucial positive regulator of the TCR signaling pathway and is required for T-cell function through the modulation of CBM complex formation.signal transduction | posttranslational modification P rotein ubiquitination is a fundamental mechanism for regulating various cellular processes, including signal transduction and transcriptional regulation (1). This process involves the attachment of ubiquitin to a target protein by a three-step enzymatic cascade, consisting of ubiquitin-activating (E1), ubiquitinconjugating (E2), and ubiquitin ligase (E3) enzymes (2). The ubiquitin conjugation process is reversible, in which the attached ubiquitin chain can be removed by deubiquitinating enzymes (DUBs), consisting of members of a protease superfamily (3). Approximately 95 putative DUBs have been identified by a human genome database search, which can be subdivided into five subclasses based on their ubiquitin protease domains: ubiquitinspecific protease (USP), ubiquitin C-terminal hydrolase (UCH), otubain protease (OTU), Machado-Joseph disease protease (MJD), and JAB1/MPN/Mov34 metalloenzyme (JAMM) (4).Although E3 ubiquitin ligases have been well studied in the immune system, the targets and physiological functions of most DUBs remain unknown. Previous studies have shown that the OTU domain-containing DUB A20 and the USP domain-containing DUB cylindromatosis protein negatively regulate NF-κB activation through deubiquitination of signaling molecules, such as RIP and TRAF2, in response to innate immune stimulation (5-7). In adaptive immunity, this is thought to involve ubiquitin-mediated regulation of key components of the T-cell receptor (TCR) signaling machinery, including the Carma1-Bcl10-Malt1 (CBM) complex (8) and Tak1 (9). How the deubiquitination system regulates the TCR-induced signaling pathway and T-cell function remains largely unclear, however.TCR-induced NF-κB activation is critical for T lymphocyte activation (10). The CBM complex, a core signaling complex of the NF-κB activation process, regulates IκB kinase (IKK) complex activation after TCR ligation. On activation by the TC...